-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
VYNE Therapeutics Inc. quarterly/annual Return On Equity history and change rate from Q3 2018 to Q2 2025.
- VYNE Therapeutics Inc. Return On Equity for the quarter ending 30 Jun 2025 was -77.6 %, a 76.4% decline year-over-year.
- VYNE Therapeutics Inc. annual Return On Equity for 2024 was -58.2 %, a 26.4% increase from 2023.
- VYNE Therapeutics Inc. annual Return On Equity for 2023 was -79.1 %, a 49.3% decline from 2022.
- VYNE Therapeutics Inc. annual Return On Equity for 2022 was -52.9 %, a 50.3% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)